GNH USA

Europe — EMA

Midiana

GNH USA supplies Midiana (Drospirenone/Ethinylestradiol), a combined oral contraceptive for prevention of pregnancy. Request a quote for global supply.

Drospirenone, Ethinylestradiol

Request sourcing

1
Pack/s

What is Drospirenone, Ethinylestradiol?

Drospirenone, the active ingredient in Midiana, is a combined oral contraceptive presented as an oral tablet for oral use. It is indicated for prevention of pregnancy in women of reproductive age.

GNH USA supplies Midiana as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Drospirenone, Ethinylestradiol used for?

Midiana, a combined oral contraceptive, is used to prevent pregnancy by inhibiting ovulation and altering cervical mucus.

Pregnancy prevention: provides reliable hormonal contraception to avoid unintended pregnancy. Contraceptive therapy: reduces the risk of accidental conception during regular sexual activity. Family planning: supports planned childbearing by offering a reversible, hormone‑based birth control method.

What are the side effects of Drospirenone, Ethinylestradiol?

Midiana may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations. - Spotting: irregular breakthrough bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: heart attack caused by coronary blockage. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes.

What precautions apply to Drospirenone, Ethinylestradiol?

Before prescribing Midiana, clinicians should evaluate patient history and risk factors. - Pregnancy contraindication: must not be used during pregnancy (Category X). - Smoking restriction: avoid in women over 35 who smoke. - Thromboembolic history: contraindicated in patients with prior clotting events. - Hypertension: use with caution in uncontrolled high blood pressure. - Liver disease: assess hepatic function before initiation. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Drospirenone, Ethinylestradiol interact with?

Midiana can interact with several medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Rifampin: strong CYP3A4 inducer that reduces contraceptive efficacy. - Carbamazepine: enzyme inducer leading to lower hormone levels. - Griseofulvin: antifungal that may diminish contraceptive effect. - St. John’s wort: herbal inducer decreasing hormone concentrations. - HIV protease inhibitors: may increase hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely): - Fluoxetine: SSRI that can increase plasma hormone concentrations. - Valproate: anticonvulsant requiring monitoring of menstrual changes. - Diuretics: may affect fluid balance and blood pressure. - Antihypertensives: possible additive blood pressure lowering. - Herbal supplements (e.g., ginseng): may interfere with hormonal metabolism.

Frequently asked questions

What is Midiana used for?+
Midiana is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and creating an environment that is unfavorable for fertilization and implantation.
How does drospirenone/ethinylestradiol work?+
The combination suppresses the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) from the pituitary gland, which stops ovulation. Drospirenone also thickens cervical mucus and alters the endometrial lining, further reducing the chance of sperm reaching an egg and of implantation.
What is the usual dose of Midiana?+
The dosing regimen for Midiana is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the specific cycle outlined in the product’s prescribing information, but the exact schedule should be confirmed with the prescriber.
Is Midiana safe to use during pregnancy or breastfeeding?+
Midiana is contraindicated in pregnancy (Category X) and must be stopped if pregnancy occurs. It is not recommended for use while breastfeeding because hormonal contraceptives can pass into breast milk and may affect milk production or the infant.
How do I order Midiana from GNH USA?+
To order Midiana, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Midiana compare with other combined oral contraceptives?+
Midiana contains drospirenone, a progestin with anti‑mineralocorticoid activity, which may result in less water retention compared with some other progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, but individual tolerability and side‑effect profiles can differ.
How should Midiana be stored and handled?+
Midiana tablets should be stored at room temperature, below 25 °C, in their original blister pack. Keep them away from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.
How is Midiana administered?+
Midiana is taken orally, usually once daily at the same time each day. The tablet is swallowed whole with water and should be started according to the prescribing schedule, often on the first day of the menstrual cycle or as directed by a healthcare provider.
What are the most serious risks associated with Midiana?+
Serious risks include venous thromboembolism (deep vein thrombosis, pulmonary embolism), arterial events such as stroke or myocardial infarction, and severe allergic reactions. Patients should be educated to seek immediate medical attention if they experience symptoms like sudden leg pain, chest pain, shortness of breath, or severe rash.
Who should not use Midiana?+
Midiana should not be used by women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, certain liver diseases, or who are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to drospirenone, ethinylestradiol, or any excipients in the tablet.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Drospirenone, Ethinylestradiol
Route
Oral Use
Manufacturer
Gedeon Richter Polska Sp. Z. O.O.
Origin
EU

Related products